By Novo Nordisk US | Published September 10, 2020
Imagine what you could do with workspace for an entire year at LabCentral, Boston’s premier, biotech-capable shared lab-facility!
Believing innovations can come from anywhere, this fall we’re calling life sciences and biotech start-ups to show they’ve got what it takes to win Golden Tickets from Novo Nordisk. Two winners bringing the boldest new thinking get, for one year, access for one scientist to get bench space at LabCentral’s state-of-the-art shared lab space in Boston.
The first Novo Nordisk-sponsored Golden Tickets were awarded in 2019 to life sciences companies Cellino Biotech, Inc. and Summation Bio. In this video, the 2019 winners share their experience and advice for future Golden Ticket participants:
LabCentral, just a short walk from Novo Nordisk’s new Boston Innovation Hub in Kendall Square, is a first-of-its-kind shared laboratory space located in the heart of Cambridge, Mass. Novo Nordisk is committed to discovering, creating and co-creating innovation to solve healthcare challenges for people living with chronic diseases and will award two Golden Tickets a year for three years.
We use Facebook as our commenting platform. By entering your comment above you acknowledge that the information you post will not only be subject to Novo Nordisk community guidelines but will be posted on Facebook in accordance with their Terms of Service and Data Policy and subject to their Community Standards.
Mary is a member of the Novo Nordisk Clinical Operations team. During the COVID-19 pandemic’s peak months in the Northeast, she returned to the bedside to care for COVID patients as a front-line nurse.